tradingkey.logo

Nanovibronix Inc

NAOV
查看詳細走勢圖
4.020USD
0.000
收盤 12/24, 13:00美東報價延遲15分鐘
4.06M總市值
虧損本益比TTM

Nanovibronix Inc

4.020
0.000
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

0.00%

1月

-2.66%

6月

-56.62%

今年開始到現在

-93.81%

1年

-93.17%

查看詳細走勢圖

TradingKey Nanovibronix Inc股票評分

單位: USD 更新時間: 2025-12-11

操作建議

Nanovibronix Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名154/209位。機構持股佔比很高,中期看,股價處於下降通道。近一個月,市場表現較差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Nanovibronix Inc評分

相關信息

行業排名
154 / 209
全市場排名
463 / 4593
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Nanovibronix Inc亮點

亮點風險
NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
業績高增長
公司營業收入穩步增長,連續3年增長240.16%
業績增長期
公司處於發展階段,最新年度總收入2.56M美元
估值高估
公司最新PE估值-0.08,處於3年歷史高位
機構加倉
最新機構持股5.95K股,環比增加28.25%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉0.00股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.99

Nanovibronix Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Nanovibronix Inc簡介

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
公司代碼NAOV
公司Nanovibronix Inc
CEOBesser (Doron)
網址https://nanovibronix.com/

常見問題

Nanovibronix Inc(NAOV)的當前股價是多少?

Nanovibronix Inc(NAOV)的當前股價是 4.020。

Nanovibronix Inc 的股票代碼是什麼?

Nanovibronix Inc的股票代碼是NAOV。

Nanovibronix Inc股票的52週最高點是多少?

Nanovibronix Inc股票的52週最高點是162.500。

Nanovibronix Inc股票的52週最低點是多少?

Nanovibronix Inc股票的52週最低點是3.550。

Nanovibronix Inc的市值是多少?

Nanovibronix Inc的市值是4.06M。

Nanovibronix Inc的淨利潤是多少?

Nanovibronix Inc的淨利潤為-3.71M。

現在Nanovibronix Inc(NAOV)的股票是買入、持有還是賣出?

根據分析師評級,Nanovibronix Inc(NAOV)的總體評級為--,目標價格為--。

Nanovibronix Inc(NAOV)股票的每股收益(EPS TTM)是多少

Nanovibronix Inc(NAOV)股票的每股收益(EPS TTM)是-51.786。
KeyAI